The problem
Four obstacles standing between children and an early answer.
No autism blood test available
The wide spectrum of autism symptoms presents significant obstacles in identifying distinct diagnostic biomarkers.
Delayed diagnosis
Behavioural assessments require children to attain a specific developmental stage. Most children with autism are not diagnosed until after age 4.
Growing problem
Autism prevalence in US children is around 1 in 36. About 1 in 6 children aged 3–17 were diagnosed with a developmental disability.
High societal cost
Autism cost the US an estimated $223B in 2020, projected to reach $589B a year by 2030.
A child showing a developmental disorder today faces this path:
5 years
is the average age at diagnosis, missing the impact of early intervention.
4 months
of waiting time in two thirds of therapy centres.
15 sessions
of assessment until a diagnosis is confirmed.
$10,000
in healthcare costs incurred before reaching a diagnosis.
Early intervention
Proactive early genetic screening of autism is proven to:
- Change medical management.
- Lead to improved cognitive, social and communication skills.
- Prepare parents ahead to identify the resources and support they will need.
- Save on long-term therapeutic costs.
Join the priority list
Early detection today changes the story of tomorrow.
If you work in autism diagnosis, research or care, we would like to hear from you.
Get in touch